These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 7913708

  • 1. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB, Yan PS, Dahiya R, Neuschwander-Tetri BA, Basbaum C, Kim YS.
    J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
    Chao CC, Huang YT, Ma CM, Chou WY, Lin-Chao S.
    Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
    Ohannesian DW, Lotan D, Lotan R.
    Cancer Res; 1994 Nov 15; 54(22):5992-6000. PubMed ID: 7954433
    [Abstract] [Full Text] [Related]

  • 5. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines.
    Chung YS, Song IS, Erickson RH, Sleisenger MH, Kim YS.
    Cancer Res; 1985 Jul 15; 45(7):2976-82. PubMed ID: 4005836
    [Abstract] [Full Text] [Related]

  • 6. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH, Lewis AD, Ehsan MN, Sikic BI.
    Cancer Res; 1991 Oct 01; 51(19):5181-7. PubMed ID: 1717140
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate.
    Augeron C, Laboisse CL.
    Cancer Res; 1984 Sep 01; 44(9):3961-9. PubMed ID: 6744312
    [Abstract] [Full Text] [Related]

  • 9. Effect of sodium butyrate on the expression of retinoblastoma (RB1) and P53 gene and phosphorylation of retinoblastoma protein in human colon tumor cell line HT29.
    Gope R, Gope ML.
    Cell Mol Biol (Noisy-le-grand); 1993 Sep 01; 39(6):589-97. PubMed ID: 8220069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Restoration by polyethylene glycol of characteristics of intestinal differentiation in subpopulations of the human colonic adenocarcinoma cell line HT29.
    Laboisse CL, Maoret JJ, Triadou N, Augeron C.
    Cancer Res; 1988 May 01; 48(9):2498-504. PubMed ID: 3281752
    [Abstract] [Full Text] [Related]

  • 12. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M, Hao XY, Larsson R, Nygren P, Tsuruo T, Mannervik B, Bergh J.
    Anticancer Res; 1993 May 01; 13(5A):1425-30. PubMed ID: 7902062
    [Abstract] [Full Text] [Related]

  • 13. Emergence of differentiated subclones from a human salivary adenocarcinoma cell clone in culture after treatment with sodium butyrate.
    Azuma M, Hayashi Y, Yoshida H, Yanagawa T, Yura Y, Ueno A, Sato M.
    Cancer Res; 1986 Feb 01; 46(2):770-7. PubMed ID: 3000585
    [Abstract] [Full Text] [Related]

  • 14. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
    Cole SP, Downes HF, Mirski SE, Clements DJ.
    Mol Pharmacol; 1990 Feb 01; 37(2):192-7. PubMed ID: 1968221
    [Abstract] [Full Text] [Related]

  • 15. Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes.
    Mestdagh N, Pommery N, Saucier JM, Hecquet B, Fournier C, Slomianny C, Teissier E, Hénichart JP.
    Anticancer Res; 1994 Feb 01; 14(3A):869-74. PubMed ID: 7915509
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differences in lipid characteristics of undifferentiated and enterocytic-differentiated HT29 human colonic cells.
    Reynier M, Sari H, d'Anglebermes M, Kye EA, Pasero L.
    Cancer Res; 1991 Feb 15; 51(4):1270-7. PubMed ID: 1671756
    [Abstract] [Full Text] [Related]

  • 19. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL, Hwang J, Perng RP, Whang-Peng J.
    Oncol Res; 1995 Feb 15; 7(1):31-8. PubMed ID: 7549042
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic instability of drug sensitivity in a human colon carcinoma cell line.
    Ferguson PJ, Cheng YC.
    Cancer Res; 1989 Mar 01; 49(5):1148-53. PubMed ID: 2563672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.